Viemed Healthcare Q2 2024 Adj. EPS $0.04 Misses $0.07 Estimate, Sales $55.000M Beat $53.800M Estimate
Portfolio Pulse from Benzinga Newsdesk
Viemed Healthcare (NASDAQ:VMD) reported Q2 2024 earnings per share of $0.04, missing the analyst estimate of $0.07 by 42.86%. However, the company reported sales of $55 million, beating the estimate of $53.8 million by 2.23%. This represents a 26.99% increase over the same period last year.
August 07, 2024 | 9:13 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Viemed Healthcare reported Q2 2024 EPS of $0.04, missing the $0.07 estimate by 42.86%, but sales of $55 million beat the $53.8 million estimate by 2.23%, showing a 26.99% YoY increase.
The mixed results, with EPS missing but sales beating estimates, create a neutral short-term impact. The significant YoY sales growth is positive, but the EPS miss tempers enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100